Skip to content

Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy

Ultrasound-assisted Bilateral Transversus Abdominis Plane Block for Open Prostatectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01625572
Acronym
TAPPro
Enrollment
66
Registered
2012-06-21
Start date
2012-07-31
Completion date
2015-12-31
Last updated
2016-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatectomy, Transversus Abdominis Plane Blockade, Pain

Keywords

general anaesthesia, epidural catheter, intravenous pain therapy

Brief summary

The purpose of this study is to compare the quality of a transversus abdominis plane blockade with an intravenous pain therapy with opioids. Due to the relatively low side effect profile and comparably few contraindications, this method offers a good option, to be a standard procedure or better alternative in the treatment of pain in surgery of the prostate.

Interventions

Bilateral one time injection of local anaesthetic in the space between the transversus abdominis muscle and obliquus internus muscle preoperatively. Follow up for three days.

PROCEDUREMorphine-patient-controlled-analgesia-device

Morphine-patient-controlled-analgesia-device for three days: 1mg/ml, Dosage 2mg bolus injection on demand every 10 minutes possible.

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients at the age of 18 and above, who need an open prostatectomy * written consent exists

Exclusion criteria

* American Society of Anaesthesiologists (ASA) classification \> III * Allergy to local anaesthesia * Contraindications to one of the applied methods * previous surgery on the abdominal wall * chronic pain patients * Myasthenia gravis * alcohol dependence * increased intraocular pressure * lacking willingness to save and hand out data within the study * Participation in another trial according to the German Drug Law * accommodation in an institute due to an official or judicial order

Design outcomes

Primary

MeasureTime frameDescription
Pain in rest in the op-area3 daysPain in rest in the op-area during the first 3 days

Secondary

MeasureTime frameDescription
Pain in motion in the op-area3 daysPain in the op-area in motion during the first three days
Pain outside the op-area3 daysPain outside the op-area during the first three days
Contentment with the pain therapy at all3 daysContentment with the pain therapy at all for the first three days
Opioid consumption3 daysopioidconsumption during the first 3 days
Incidence of pruritus3 daysIncidence of pruritus during the first three days
Tenesmuses of the bladder3 daysTenesmus of the bladder during the first three days
Contentment of the Patient at all3 daysContentment of the patient at all during the first three days
Frequency of postoperative vomiting and nausea3 daysFrequency of postoperative vomiting and nausea during the first three days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026